design
inhibitor
sever
acut
respiratori
syndrom
sar
chymotrypsinlik
proteas
pro
potenti
import
approach
fight
sar
develop
sever
synthet
inhibitor
structurebas
drug
design
report
reveal
two
crystal
structur
sar
pro
complex
two
new
inhibitor
base
previou
work
structur
combin
six
crystal
structur
complex
seri
relat
ligand
report
us
collect
analyz
eight
complex
structur
basi
inhibitor
bind
analyz
combin
method
chemometr
analysi
optim
proteinligand
complex
analysi
reveal
first
two
latent
variabl
gave
cumul
contribut
ratio
r
interestingli
score
use
second
latent
variabl
complex
strongli
correl
root
mean
squar
deviat
rmsd
sidechain
heavi
atom
met
intact
crystal
structur
pro
r
enlarg
pocket
substanti
contribut
side
chain
explan
pic
depend
stereochemistri
chemic
structur
ligand
adapt
pocket
proteas
thu
start
substrat
mimic
inhibitor
design
central
scaffold
low
molecular
weight
inhibitor
evalu
develop
potent
inhibitor
v
c
wiley
period
inc
biopolym
pept
sci
keyword
sar
proteas
inhibitor
azadecalin
sar
proteas
crystal
structur
complex
inhibitor
azadecalin
scaffold
combin
analysi
inhibitor
design
hydrophob
interact
articl
origin
publish
onlin
accept
preprint
publish
onlin
date
correspond
preprint
version
request
copi
preprint
past
two
calendar
year
email
biopolym
editori
offic
biopolym
wileycom
lthough
primari
epidem
sever
acut
respiratori
syndrom
sar
eventu
brought
control
recent
identif
sar
cov
coronaviru
like
viru
chines
bat
indic
natur
reservoir
viru
sinc
effect
therapi
exist
viral
infect
develop
antisar
agent
futur
outbreak
remain
formid
challeng
earli
stage
infect
sar
proteas
pro
key
enzym
cleav
polyprotein
yield
function
polypeptid
replic
pro
cystein
proteas
contain
cyshi
catalyt
dyad
function
import
viral
lifecycl
pro
consid
attract
target
structurebas
design
drug
sar
thu
numer
inhibitor
pro
report
includ
peptidemim
small
molecul
deriv
natur
product
antivir
agent
antimalaria
agent
high
throughput
screen
cours
studi
sar
pro
inhibitor
found
matur
sar
pro
sensit
degrad
site
mutant
resist
degrad
result
stabl
mutant
proteas
make
feasibl
evalu
design
synthes
inhibitor
explor
use
inhibitor
sar
pro
base
substrat
reveal
peptid
aldehyd
facil
design
inhibitor
sar
pro
combin
systemat
substitut
peptid
aldehyd
amino
acid
crystallograph
analysi
complex
lead
inhibitor
tabl
entri
emerg
peptidebas
inhibitor
sidechain
structur
differ
substrat
nonprim
site
sequenc
thrseralavalleugln
except
p
site
sidechain
direct
outward
especi
substitut
leu
cyclohexyl
alanin
cha
p
peptid
inhibitor
gave
higher
increas
inhibitori
potenc
sar
pro
tabl
entri
moreov
crystallograph
analysi
inhibitor
complex
provid
extend
design
delet
p
residu
mutat
provid
hetero
atom
p
posit
inhibitor
evalu
ic
proteas
crystallograph
analysi
reveal
size
design
clearli
realiz
without
substanti
decreas
potenc
tabl
entri
base
wide
rang
surveil
surround
activ
site
peptid
aldehyd
inhibitor
novel
nonpeptid
inhibitor
base
interact
site
sar
pro
design
synthes
studi
focus
fact
p
p
site
interact
catalyt
dyad
hydrophob
pocket
respect
compound
design
connect
p
site
cyclohexyl
group
substratebas
inhibitor
mainchain
atom
p
posit
cha
via
methylen
linker
strategi
gave
azadecalin
central
scaffold
inhibitor
expect
restrict
conform
divers
p
site
design
compound
show
substanti
inhibitori
activ
xray
crystallograph
studi
figur
confirm
azadecalin
inhibitor
activ
site
cleft
pro
azadecalin
scaffold
insert
larg
pocket
pocket
occupi
interestingli
stereochemistri
azadecalin
scaffold
show
clear
differ
inhibitori
activ
sar
pro
tabl
entri
thu
start
substrat
mimic
peptid
aldehyd
lead
compound
develop
nonpeptid
inhibitor
extract
fine
structureact
relationship
crystallograph
analys
howev
stereostructureact
relationship
fulli
evalu
shortag
sampl
structur
comparison
compar
bind
energi
combin
method
develop
ortiz
power
pipelin
decomposit
ligandreceptor
interact
energi
seri
term
extract
latent
variabl
lv
explan
interact
assign
weight
select
ligandresidu
interact
use
multivari
statist
partial
least
squar
pl
analysi
correl
set
ligandreceptor
complex
data
experiment
activ
bind
affin
gilredondo
colleagu
develop
gcombin
userfriendli
graphic
interfac
perform
analysi
defin
input
file
sophist
result
present
sinc
ligandinduc
structur
altern
taken
account
ligandreceptor
interact
better
understood
chemometr
analysi
method
appli
variou
analys
quantit
structureact
relationship
get
insight
relat
configur
side
chain
azadecalin
scaffold
structur
complex
analyz
two
new
complex
ligand
azadecalin
scaffold
structur
previous
report
six
crystal
structur
complex
seri
ligand
one
crystal
structur
without
ligand
collect
refer
deriv
quantit
model
present
studi
two
inhibitor
newli
synthes
examin
inhibitori
activ
inhibitor
complex
sar
pro
complex
subject
xray
structur
analysi
structur
analys
anoth
six
complex
structur
contain
previous
develop
inhibitor
subject
gcombin
chemometr
analysi
tabl
show
chemic
structur
pdb
id
properti
inhibitor
inhibitor
synthes
base
scheme
previous
describ
modif
briefli
start
enantiomixtur
alcohol
previous
report
product
dielsald
reaction
primari
alcohol
convert
azid
amino
group
b
amin
b
condens
nbocnphenyl
balanin
ph
boc
bala
afford
enantiomixtur
compound
c
precursor
cycliz
reaction
amid
c
nitrogen
amid
group
locat
apart
olefin
cycliz
pdbase
catalysi
obtain
enantiomixtur
azadecalin
deriv
olefin
convert
diol
aldehyd
lemieuxjohnson
oxid
result
azadecalinederiv
aldehyd
hhi
trt
n
ch
och
condens
via
reduct
amin
give
diastereomixtur
compound
e
diastereomixtur
separ
purifi
flash
column
chromatographi
correspond
stereochemistri
respect
trt
boc
group
remov
purifi
silica
column
final
weinreb
amid
convert
aldehyd
purifi
rphplc
yield
respect
base
enantiomixtur
olefin
teruya
et
al
aq
tfa
min
cleavag
rate
calcul
decreas
substrat
peak
area
ic
valu
obtain
sigmoid
doserespons
curv
chemic
structur
potenc
list
tabl
purifi
sar
pro
mm
bistri
mm
nacl
mm
dtt
concentr
mgml
crystal
sar
pro
grown
use
sittingdrop
vapor
diffus
method
mix
equal
volum
reservoir
solut
contain
mm
me
ph
mm
dtt
cubicshap
crystal
dimens
mm
mm
mm
grew
within
day
crystal
soak
hour
reservoirbas
solut
mm
me
ph
mm
dtt
contain
mm
crystal
transfer
cryobuff
mm
me
ph
mm
dtt
ethylen
glycol
contain
mm
flashfrozen
nitrogen
stream
k
xray
diffract
data
sar
pro
complex
inhibitor
collect
beamlin
rayonix
ccd
detector
wavelength
structur
sar
pro
complex
inhibitor
determin
molecular
replac
use
molrep
program
sar
pro
structur
pdb
code
search
model
rigid
bodi
refin
subsequ
restrain
refin
protocol
perform
program
refmac
ccp
packag
coot
program
use
manual
model
rebuild
water
molecul
ad
use
coot
refin
protein
structur
converg
ligand
gener
jligand
softwar
directli
built
correspond
differ
electron
densiti
model
subject
addit
round
refin
figur
structur
represent
paper
gener
pymol
ucsfchimera
softwar
crystallograph
data
result
refin
summar
tabl
ii
gcombin
analysi
pdb
file
complex
correspond
pdb
id
prepar
contain
singl
complex
ligand
complex
impos
structur
sar
pro
without
ligand
pdb
id
matchmak
program
base
main
chain
ca
proteas
complex
proton
minim
forc
field
power
mmtk
inhibitor
assign
charg
fulli
optim
level
use
mopac
program
ucsfchimera
proteas
inhibitor
save
separ
parametr
gcombin
perform
tleap
modul
program
suit
pdb
file
receptor
proteas
clean
antechamb
suit
develop
use
gener
amber
forc
field
small
molecul
pdb
file
inhibitor
convert
file
antechamb
frcmod
lib
file
inhibitor
gener
parmchk
file
proteas
inhibitor
combin
neutriz
complex
paramet
topolog
file
gener
combin
program
use
decompos
interact
energi
inhibitor
protein
complex
program
use
calcul
lennardjon
electrostat
interact
inhibitor
protein
residu
per
residu
basi
gcombin
graphic
interfac
run
combin
gcombin
automat
arrang
construct
x
matrix
row
repres
differ
compound
studi
column
contain
residuebas
energi
inform
separ
two
block
van
der
waal
electrostat
plu
addit
column
matrix
contain
experiment
bind
affin
x
matrix
project
onto
small
number
orthogon
lv
use
partial
leastsquar
pl
analysi
origin
energi
term
given
weight
w
accord
import
model
form
pl
pseudo
coeffici
higher
coeffici
signific
explain
varianc
experiment
data
thu
studi
van
der
waal
interact
u
vdw
electrostat
interact
u
ele
inhibitor
protein
residu
select
estim
pic
valu
variabl
unimport
activ
discard
remain
variabl
use
build
design
prepar
inhibitori
activ
inhibitor
compound
design
base
previou
structur
analysi
pro
compound
figur
show
summari
previou
structur
analysi
complex
chemistri
azadecalin
deriv
inhibitor
includ
divid
three
portion
histidin
aldehyd
hisal
azadecalin
nacyl
part
figur
hisal
part
took
almost
ident
conform
similarli
interact
pro
complex
examin
briefli
hisal
locat
activ
center
pro
aldehyd
imidazol
ring
interact
catalyt
dyad
thiol
cy
imidazol
respect
thu
hisal
part
function
pharmacophor
compound
contrast
nacyl
part
azadecalin
base
inhibitor
direct
outward
pro
opposit
p
p
site
peptid
mimic
inhibitor
base
observ
compound
design
make
aromat
ring
nacyl
part
feasibl
access
pocket
pro
via
rel
flexibl
balanin
linker
expect
provid
greater
potenc
stereochemistri
compound
correspond
compound
respect
templat
synthesi
design
compound
azadecalin
attract
scaffold
restrict
configur
provid
distinct
rel
posit
direct
substitu
consid
abil
extens
among
three
part
basic
inhibitor
design
azadecalin
construct
two
cycliz
step
util
differ
chemistri
dielsald
diastereoselect
cycliz
pdcl
accn
cyclohexyl
azacyclohexyl
cyclohexyl
respect
sinc
second
cycliz
feasibl
react
wide
varieti
substrat
acyl
schedul
earli
step
hand
sinc
hisal
part
contain
labil
group
aldehyd
reduct
amin
schedul
late
step
present
studi
synthet
scheme
work
well
least
synthesi
inhibitor
product
wide
varieti
inhibitor
contain
variou
stereochemistri
examin
elsewher
base
key
reaction
although
compound
design
base
structur
analysi
mention
earlier
ic
improv
comparison
correspond
compound
respect
compound
inhibit
hydrolysi
sar
pro
ic
lm
lm
respect
investig
reason
deterior
ic
crystallograph
analys
sar
pro
complex
compound
perform
data
collect
refin
statist
sar
proteas
compound
summar
tabl
ii
overal
structur
pro
complex
inhibitor
similar
azadecalinebas
inhibitor
figur
briefli
aldehyd
group
imidazol
ring
hisal
inhibitor
took
almost
ident
conform
similarli
interact
pro
contrast
direct
azasubstitu
azadecalin
base
inhibitor
figur
outward
pro
opposit
p
p
site
peptid
mimic
inhibitor
previou
inhibitor
figur
thu
crystallograph
analys
sar
pro
complex
compound
reveal
case
bala
function
flexibl
linker
reach
ph
group
hydrophob
pocket
featur
good
accord
deterior
ic
may
due
higher
entrop
discord
respect
tran
azadecalin
scaffold
adapt
pocket
deep
respect
base
structur
analys
focus
chemic
structur
inhibitor
sever
point
increas
potenc
reveal
azadecalin
structur
suffici
adapt
pocket
stereochemistri
azadecalin
determin
orient
pocket
figur
interestingli
orient
azadecalin
pocket
critic
determin
rel
potenc
better
respect
scaffold
almost
cross
perpendicular
complex
structur
superimpos
whole
protein
thu
tran
azadecalin
scaffold
suitabl
embed
pocket
comparison
peptid
aldehyd
inhibitor
figur
make
nacylgroup
azadecalin
base
inhibitor
feasibl
interact
site
regioisom
tran
azadecalin
may
necessari
paasch
et
al
point
low
inhibit
potenc
known
coval
interact
inhibitor
may
least
part
attribut
insuffici
foster
protontransf
reaction
base
mmmq
analysi
sar
pro
unfortun
method
studi
incap
access
charg
state
cleari
colleagu
show
acet
hemiacet
format
one
compon
inhibitori
potenc
chymotrypsin
among
eight
complex
use
studi
structur
refin
result
distanc
carbonyl
carbon
sulfid
rang
within
includ
distanc
judg
chemic
bond
format
model
softwar
howev
correl
distanc
potenc
r
investig
structur
basi
sar
pro
base
result
chemometr
analysi
appli
crystallograph
structur
complex
inhibitor
ligand
includ
peptid
aldehyd
larg
enough
cover
nonprim
site
p
p
two
pair
diasteroisom
tran
azadecalin
respect
expect
give
fine
structur
divers
around
activ
site
input
combin
program
structur
data
includ
topolog
file
coordin
file
pharmacolog
activ
correl
ligand
bind
studi
ic
valu
convert
neg
logarithm
valu
pic
correl
bind
free
energi
inhibitor
tabl
valu
rang
list
inhibitor
ligand
chemic
structur
base
input
static
structur
program
comput
residuebas
van
der
waal
electrostat
interact
residu
complex
ligand
complex
figur
ligandbind
pocket
clearli
detect
pocket
locat
structur
domain
figur
reveal
contribut
inhibitor
bind
pocket
extens
even
region
examin
inhibitor
interact
ident
aldehyd
structur
calcul
energi
ident
result
illustr
substitut
affect
fine
interact
pharmacophor
energi
descriptor
complex
correspond
pic
compris
x
matrix
gcombin
analysi
respect
combin
program
pl
analysi
compos
x
matrix
project
onto
small
number
orthogon
lv
optim
manner
proteinligand
interact
tabl
iii
show
chemometr
summari
analysi
indic
lv
optim
dimension
pl
model
determin
monitor
crossvalid
index
function
number
lv
extract
crossvalid
procedur
employ
leaseoneout
method
predict
abil
result
model
report
crossvalid
correl
coeffici
q
standard
deviat
error
predict
q
valu
serv
criterion
determin
optim
dimension
pl
model
thu
analysi
decid
take
rank
model
rank
linear
regress
analysi
reach
r
correl
coeffici
similar
primari
compon
analysi
indic
first
second
lv
contribut
explan
pic
system
respect
result
indic
first
two
lv
explain
pic
complex
consider
extent
combin
program
gave
sever
file
correspond
rank
lv
fact
complex
predict
pic
teruya
et
al
first
two
lv
experiment
pic
good
correl
clearli
correl
correspond
experiment
pic
shown
figur
consequ
complex
compos
wide
rang
pic
order
p
matrix
xload
pl
lv
reflect
much
residu
protein
contribut
figur
show
scatter
plot
part
residu
compos
first
second
lv
horizont
vertic
axe
respect
among
element
reflect
featur
first
two
lv
top
contribut
residu
interact
pro
glu
met
leu
tyr
gln
hand
met
promin
contribut
larg
portion
second
lv
first
lv
residu
mainli
compos
pocket
residu
cover
wide
rang
bind
site
extract
thu
first
lv
interpret
stand
briefli
first
lv
inhibit
reflect
fact
pharmacophor
interact
activ
site
fasten
part
pharmacophor
interact
wide
rang
bind
site
seen
peptid
mimic
inhibitor
interact
pro
inhibitor
complex
residu
resolut
vertic
horizont
axe
repres
comput
energi
van
der
waal
upper
graph
electrostat
lower
graph
interact
residu
number
pro
respect
top
schemat
draw
secondari
structur
pro
along
residu
number
present
next
pocket
highlight
examin
residu
relat
second
lv
among
residu
reveal
configur
domin
met
connect
inhibitori
effect
ligand
bind
figur
show
activ
site
superimpos
total
pro
structur
structur
contain
inhibitor
catalyt
cyshi
dyad
well
overlap
hand
configur
met
side
chain
separ
two
group
one
group
ligand
leu
side
chain
azadecalin
involv
group
cha
side
chain
azadecalin
involv
inhibitor
latter
group
greater
potenc
comparison
correspond
chemic
structur
thu
pocket
enlarg
potent
inhibitor
reorient
met
side
chain
figur
show
correl
x
score
complex
correspond
second
lv
model
rmsd
met
side
chain
heavi
atom
complex
structur
valu
strongli
correl
r
thu
main
contribut
second
lv
orient
met
side
chain
follow
enlarg
pocket
isobutyl
group
leu
side
chain
suffici
induc
reorient
even
larg
function
group
azadecalin
occupi
pocket
angl
plane
consist
chairchair
configur
azadecalin
met
critic
configur
chang
control
stereochemistri
posit
azadecalin
scaffold
analys
reveal
azadecalin
scaffold
stereochemistri
posit
novel
scaffold
design
inhibitor
pro
mention
inhibitorbas
analysi
optim
regioisom
need
elucid
key
featur
interact
pocket
give
novel
strategi
develop
new
inhibitor
import
uniqu
strategi
combin
multipl
structur
involv
analysi
combin
strategi
may
least
part
repres
flexibl
protein
upon
ligand
bind
research
protein
dynam
structur
chang
configur
chang
side
chain
inhibitor
bind
substanti
control
inhibitori
potenc
detect
fact
highlight
advantag
combin
method
togeth
ligandbas
analysi
comibin
analysi
focus
figur
scatter
plot
amino
acid
residu
contribut
lv
vertic
horizont
axe
correspond
first
second
lv
respect
relev
energi
descriptor
label
teruya
et
al
protein
structur
peptid
mimet
inhibitor
develop
small
molecular
weight
molecul
feasibl
set
train
combin
adapt
model
complex
dock
simul
conclus
peptid
proteas
inhibitor
abl
increas
potenc
design
base
structur
analysi
design
step
azadecalin
base
inhibitor
potenc
decreas
design
structur
analysi
reveal
orient
substitu
azadecalin
scaffold
suitabl
interact
protein
combin
analysi
reveal
volum
pocket
perturb
stereochemistri
ligand
import
inhibitor
potenc
deriv
second
lv
explan
x
matrix
design
synthesi
inhibitor
expect
